Literature DB >> 24065336

Yield of contact investigations in households of patients with drug-resistant tuberculosis: systematic review and meta-analysis.

N Sarita Shah1, Courtney M Yuen, Moonseong Heo, Arielle W Tolman, Mercedes C Becerra.   

Abstract

Contact investigations among individuals living with drug-susceptible tuberculosis patients (source cases) have shown a high yield of tuberculosis disease and latent tuberculosis, but the yield of such investigations in households of drug-resistant tuberculosis source cases is unknown. In this systematic review and meta-analysis, we found 25 studies that evaluated a median of 111 (interquartile range, 21-302) household contacts of drug-resistant tuberculosis source cases. The pooled yield was 7.8% (95% CI, 5.6%-10.0%) for active tuberculosis and 47.2% (95% CI, 30.0%-61.4%) for latent tuberculosis, although there was significant statistical heterogeneity (P < .0001). More than 50% of secondary cases with drug susceptibility test results were concordant with those of the source case. Among studies that followed household members, the majority of secondary cases were detected within 1 year of the source case's diagnosis. Household contact investigation around drug-resistant tuberculosis patients is a high-yield intervention for detection of drug-resistant tuberculosis and prevention of ongoing transmission.

Entities:  

Keywords:  contact; drug resistance; transmission; tuberculosis

Mesh:

Year:  2013        PMID: 24065336      PMCID: PMC3890332          DOI: 10.1093/cid/cit643

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  53 in total

1.  Household contact investigation of multidrug-resistant and extensively drug-resistant tuberculosis in a high HIV prevalence setting.

Authors:  V Vella; V Racalbuto; R Guerra; C Marra; A Moll; Z Mhlanga; M Maluleke; H Mhlope; B Margot; G Friedland; N S Shah; N R Gandhi
Journal:  Int J Tuberc Lung Dis       Date:  2011-09       Impact factor: 2.373

2.  Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study.

Authors:  Salmaan Keshavjee; Irina Y Gelmanova; Paul E Farmer; Sergey P Mishustin; Aivar K Strelis; Yevgeny G Andreev; Alexander D Pasechnikov; Sidney Atwood; Joia S Mukherjee; Michael L Rich; Jennifer J Furin; Edward A Nardell; Jim Y Kim; Sonya S Shin
Journal:  Lancet       Date:  2008-08-22       Impact factor: 79.321

3.  Two-sided confidence intervals for the single proportion: comparison of seven methods.

Authors:  R G Newcombe
Journal:  Stat Med       Date:  1998-04-30       Impact factor: 2.373

4.  The competitive cost of antibiotic resistance in Mycobacterium tuberculosis.

Authors:  Sebastien Gagneux; Clara Davis Long; Peter M Small; Tran Van; Gary K Schoolnik; Brendan J M Bohannan
Journal:  Science       Date:  2006-06-30       Impact factor: 47.728

5.  High hepatotoxicity of pyrazinamide and ethambutol for treatment of latent tuberculosis.

Authors:  A B Younossian; T Rochat; J-P Ketterer; J Wacker; J-P Janssens
Journal:  Eur Respir J       Date:  2005-09       Impact factor: 16.671

Review 6.  Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low-income and middle-income countries: a systematic review and meta-analysis.

Authors:  Janina Morrison; Madhukar Pai; Philip C Hopewell
Journal:  Lancet Infect Dis       Date:  2008-04-29       Impact factor: 25.071

7.  HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality.

Authors:  Neel R Gandhi; N Sarita Shah; Jason R Andrews; Venanzio Vella; Anthony P Moll; Michelle Scott; Darren Weissman; Claudio Marra; Umesh G Lalloo; Gerald H Friedland
Journal:  Am J Respir Crit Care Med       Date:  2009-10-15       Impact factor: 21.405

8.  Tuberculosis infection and disease in children living in households of Filipino patients with tuberculosis: a preliminary report.

Authors:  R M L Salazar-Vergara; I G Sia; T E Tupasi; M R Alcañeses; R B Orillaza; V Co; M I D Quelapio; G Beltran; J D Legaspi; M P C Rostrata; M E B Tecson; M L S B Corpuz
Journal:  Int J Tuberc Lung Dis       Date:  2003-12       Impact factor: 2.373

9.  Comprehensive treatment of extensively drug-resistant tuberculosis.

Authors:  Carole D Mitnick; Sonya S Shin; Kwonjune J Seung; Michael L Rich; Sidney S Atwood; Jennifer J Furin; Garrett M Fitzmaurice; Felix A Alcantara Viru; Sasha C Appleton; Jaime N Bayona; Cesar A Bonilla; Katiuska Chalco; Sharon Choi; Molly F Franke; Hamish S F Fraser; Dalia Guerra; Rocio M Hurtado; Darius Jazayeri; Keith Joseph; Karim Llaro; Lorena Mestanza; Joia S Mukherjee; Maribel Muñoz; Eda Palacios; Epifanio Sanchez; Alexander Sloutsky; Mercedes C Becerra
Journal:  N Engl J Med       Date:  2008-08-07       Impact factor: 91.245

10.  Early outcomes of MDR-TB treatment in a high HIV-prevalence setting in Southern Africa.

Authors:  Kwonjune J Seung; David B Omatayo; Salmaan Keshavjee; Jennifer J Furin; Paul E Farmer; Hind Satti
Journal:  PLoS One       Date:  2009-09-25       Impact factor: 3.240

View more
  44 in total

1.  Estimating the global burden of multidrug-resistant tuberculosis among prevalent cases of tuberculosis.

Authors:  S Nourzad; H E Jenkins; M Milstein; C D Mitnick
Journal:  Int J Tuberc Lung Dis       Date:  2017-01-01       Impact factor: 2.373

2.  Feasibility of Identifying Household Contacts of Rifampin-and Multidrug-resistant Tuberculosis Cases at High Risk of Progression to Tuberculosis Disease.

Authors:  Amita Gupta; Susan Swindells; Soyeon Kim; Michael D Hughes; Linda Naini; Xingye Wu; Rodney Dawson; Vidya Mave; Jorge Sanchez; Alberto Mendoza; Pedro Gonzales; Nagalingeswaran Kumarasamy; Kyla Comins; Francesca Conradie; Justin Shenje; Sandy Nerette Fontain; Anthony Garcia-Prats; Aida Asmelash; Supalert Nedsuwan; Lerato Mohapi; Umesh G Lalloo; Ana Cristina Garcia Ferreira; Christopher Mugah; Mark Harrington; Lynne Jones; Samyra R Cox; Betsy Smith; N Sarita Shah; Anneke C Hesseling; Gavin Churchyard
Journal:  Clin Infect Dis       Date:  2020-01-16       Impact factor: 9.079

3.  Resource utilization for multidrug-resistant tuberculosis household contact investigations (A5300/I2003).

Authors:  S Swindells; A Gupta; S Kim; M D Hughes; J Sanchez; V Mave; R Dawson; N Kumarasamy; K Comins; B Smith; R Rustomjee; L Naini; N S Shah; A Hesseling; G Churchyard
Journal:  Int J Tuberc Lung Dis       Date:  2018-09-01       Impact factor: 2.373

4.  Transmission of Extensively Drug-Resistant Tuberculosis in South Africa.

Authors:  N Sarita Shah; Sara C Auld; James C M Brust; Barun Mathema; Nazir Ismail; Pravi Moodley; Koleka Mlisana; Salim Allana; Angela Campbell; Thuli Mthiyane; Natashia Morris; Primrose Mpangase; Hermina van der Meulen; Shaheed V Omar; Tyler S Brown; Apurva Narechania; Elena Shaskina; Thandi Kapwata; Barry Kreiswirth; Neel R Gandhi
Journal:  N Engl J Med       Date:  2017-01-19       Impact factor: 91.245

Review 5.  Transmission of Mycobacterium Tuberculosis in Households and the Community: A Systematic Review and Meta-Analysis.

Authors:  Leonardo Martinez; Ye Shen; Ezekiel Mupere; Allan Kizza; Philip C Hill; Christopher C Whalen
Journal:  Am J Epidemiol       Date:  2017-06-15       Impact factor: 4.897

Review 6.  Transmission of drug-resistant tuberculosis in HIV-endemic settings.

Authors:  Palwasha Y Khan; Tom A Yates; Muhammad Osman; Robin M Warren; Yuri van der Heijden; Nesri Padayatchi; Edward A Nardell; David Moore; Barun Mathema; Neel Gandhi; Vegard Eldholm; Keertan Dheda; Anneke C Hesseling; Valerie Mizrahi; Roxana Rustomjee; Alexander Pym
Journal:  Lancet Infect Dis       Date:  2018-12-13       Impact factor: 25.071

7.  Diagnosis and Management of Multidrug-Resistant Tuberculosis in Children: A Practical Approach.

Authors:  H Simon Schaaf
Journal:  Indian J Pediatr       Date:  2019-01-17       Impact factor: 1.967

8.  HIV testing uptake among the household contacts of multidrug-resistant tuberculosis index cases in eight countries.

Authors:  V S Opollo; X Wu; M D Hughes; S Swindells; A Gupta; A Hesseling; G Churchyard; S Kim; R Lando; R Dawson; V Mave; A Mendoza; P Gonzales; N Kumarasamy; F von Groote-Bidlingmaier; F Conradie; J Shenje; S N Fontain; A Garcia-Prats; A Asmelash; S Nedsuwan; L Mohapi; R Mngqibisa; A C Garcia Ferreira; E Okeyo; L Naini; L Jones; B Smith; N S Shah
Journal:  Int J Tuberc Lung Dis       Date:  2018-12-01       Impact factor: 2.373

9.  Significant clinical impact of a rapid molecular diagnostic test (Genotype MTBDRplus assay) to detect multidrug-resistant tuberculosis.

Authors:  Maia Kipiani; Veriko Mirtskhulava; Nestani Tukvadze; Matthew Magee; Henry M Blumberg; Russell R Kempker
Journal:  Clin Infect Dis       Date:  2014-08-04       Impact factor: 9.079

10.  Reply to Hong-min et al.

Authors:  N Sarita Shah; Courtney M Yuen; Moonseong Heo; Arielle W Tolman; Mercedes C Becerra
Journal:  Clin Infect Dis       Date:  2015-09-23       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.